Quick Answer
Stemtech Corp reported Total Revenue of $5.05 million for the year ending 2024.
- Stemtech Corp showed an increase of +2.7% in Total Revenue from 2023 to 2024.
- This data is from Stemtech Corp's annual report (Form 10-K), filed with the SEC on June 30, 2025.
- XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $1.06 million | Q1 2021: $1.08 million | Q2 2021: $1.03 million | Q3 2021: $907.9 thousand | Q1 2022: $1.16 million | Q2 2022: $1.28 million | Q3 2022: $1.05 million | Q1 2023: $1.13 million | Q2 2023: $1.13 million | Q3 2023: $1.30 million | Q1 2024: $1.38 million | Q2 2024: $1.33 million | Q3 2024: $1.03 million | Q1 2025: $868.0 thousand | Q2 2025: $697.9 thousand | Q3 2025: $852.3 thousand.
- Over the full 5 years of available data (2020 to 2024), Stemtech Corp's Total Revenue has grown by 15.3%.
- Historical annual values: Fiscal year 2024: $5.05 million | Fiscal year 2023: $4.92 million | Fiscal year 2022: $4.56 million | Fiscal year 2021: $4.32 million | Fiscal year 2020: $4.38 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: